Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 12/1/2025

Medication-Induced Low Libido

  • Spironolactone causes decreased libido in more than 10% of patients through its anti-androgenic properties, affecting both men and women, with men experiencing decreased testosterone production and women experiencing menstrual irregularities and decreased arousal 1, 2, 3
  • The European Society of Cardiology recommends considering alternative treatments in patients with pre-existing sexual dysfunction, as spironolactone caused gynecomastia in 10% of men in the RALES trial 2
  • Alternative diuretics such as hydrochlorothiazide or chlorthalidone lack anti-androgenic effects and should be considered when sexual function is a concern 2
  • Fluoxetine causes sexual dysfunction, including decreased libido, in 34-58% of patients, with rates varying depending on whether patients are directly questioned or spontaneously reporting symptoms 1, 4
  • The American Urological Association notes that SSRIs, including fluoxetine, are effective for treating premature ejaculation, with some patients preferring to maintain the delayed ejaculation effect 4
  • Among SSRIs, paroxetine shows the highest rates of sexual dysfunction, causing more delay of orgasm/ejaculation and impotence than fluoxetine, sertraline, or fluvoxamine 1, 4

Management Approach

  • For spironolactone, consider alternative diuretics or aldosterone antagonists without anti-androgenic effects when sexual function is a priority 2
  • For fluoxetine, dose reduction may help as effects are dose-related, and switching to medications with different mechanisms may result in improvement in sexual function 2, 4

REFERENCES

1

Pharmacological Management of Hypersexuality [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

2

Spironolactone Safety Considerations in Patients with Pre-existing Sexual Dysfunction [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025